IGF-1 LR3 Research Overview
Long R3 IGF-I is an engineered insulin-like growth factor analog used in laboratory research. It is not the same molecule as native human IGF-I, and findings from one experimental system should not be assumed to apply to another.
How Long R3 differs from native IGF-I
The analog was designed with sequence changes that alter its interactions in experimental systems, including interactions involving IGF-binding proteins. That is why papers may use Long R3 IGF-I to probe IGF-receptor signaling or to separate receptor effects from some binding-protein effects. The experimental purpose matters more than the shorthand name.
What research models have examined
Published studies include cell systems and animal models investigating growth signaling, metabolism, organ development, and the somatotropic axis. These are not all studies of the same question. Species, tissue, exposure method, assay timing, and endpoint can change the interpretation substantially.
Some papers use the analog as a laboratory reagent rather than as the primary subject of the paper. Researchers should therefore read the methods section and identify the exact material, concentration, model, controls, and measured endpoint before citing a result.
Quality and interpretation checklist
- Confirm that the material is specifically Long R3 IGF-I rather than native IGF-I or another analog.
- Match the lot and labeled strength to current analytical documentation.
- Separate chemical identity, chromatographic purity, and measured biological activity.
- Record the cell line, species, tissue, assay, time point, and comparison group.
- Avoid turning preclinical findings into personal-use or outcome claims.
Use the IGF-1 LR3 research calculator for transparent arithmetic from values your laboratory supplies, or view the current catalog listing.